Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
hypofractionation radiotherapy
RADIATION
2 trials
Sponsors
Chinese Academy of Medical Sciences
, The First Affiliated Hospital of Xiamen University
Conditions
Breast Cancer
Colorectal Neoplasms
Phase 2
Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC
NCT05292417
The First Affiliated Hospital of Xiamen University
Colorectal Neoplasms
Start: 2022-03-25
End: 2024-03-31
Target: 71
Updated: 2022-03-31
Phase 3
A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer
Completed
NCT00793962
Chinese Academy of Medical Sciences
Breast Cancer
Start: 2008-06-30
End: 2018-09-30
Updated: 2018-10-11
Related Papers
Delay in Initiating Postmastectomy Radiotherapy is Associated With Inferior Clinical Oncologic Outcomes for High-Risk Breast Cancer.
2021-11-01
Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer.
2021-04-19
8 citations
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
2019-01-30
255 citations